Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 8:42 pm Purchase |
2023-12-31 | 13G | Pharvaris N.V. PHVS |
Venrock Healthcare Capital Partners III L.P. | 3,395,606 6.500% |
912,000 (+36.72%) |
Filing History |
| 2024-02-14 10:27 am Purchase |
2023-12-31 | 13G | Pharvaris N.V. PHVS |
VIKING GLOBAL INVESTORS LP | 3,656,923 7.000% |
425,000 (+13.15%) |
Filing History |
| 2024-02-13 2:14 pm Purchase |
2023-12-31 | 13G | Pharvaris N.V. PHVS |
Foresite Capital Fund IV, L.P. | 4,038,842 7.800% |
757,774 (+23.10%) |
Filing History |
| 2024-02-13 10:12 am Purchase |
2023-12-31 | 13G | Pharvaris N.V. PHVS |
GENERAL ATLANTIC PARTNERS LLC | 7,531,252 14.100% |
3,125,000 (+70.92%) |
Filing History |
| 2024-02-09 09:28 am Purchase |
2024-02-08 | 13G | Pharvaris N.V. PHVS |
FMR CORP | 5,192,984 9.989% |
1,877,746 (+56.64%) |
Filing History |
| 2024-02-08 4:16 pm Sale |
2023-12-31 | 13G | Pharvaris N.V. PHVS |
LSP V Cooperatieve U.A. | 3,556,805 6.800% |
-50,761 (-1.41%) |
Filing History |
| 2024-01-24 6:41 pm Purchase |
2023-12-06 | 13D | Pharvaris N.V. PHVS |
venBio Global Strategic Fund III L.P. | 4,382,504 8.400% |
117,832 (+2.76%) |
Filing History |
| 2024-01-22 4:30 pm Sale |
2024-01-18 | 13G | Pharvaris N.V. PHVS |
BCLS I Investco, LP | 1,967,093 3.800% |
-918,173 (-31.82%) |
Filing History |
| 2023-11-30 4:15 pm Purchase |
2023-11-20 | 13G | Pharvaris N.V. PHVS |
Venrock Healthcare Capital Partners III L.P. | 2,483,606 6.100% |
2,483,606 (New Position) |
Filing History |
| 2023-06-23 4:34 pm Unchanged |
2023-06-21 | 13G | Pharvaris N.V. PHVS |
BCLS I Investco, LP | 2,885,266 7.100% |
0 (Unchanged) |
Filing History |
| 2023-06-23 3:07 pm Purchase |
2023-06-21 | 13G | Pharvaris N.V. PHVS |
GENERAL ATLANTIC PARTNERS LLC | 4,406,252 10.800% |
1,986,097 (+82.06%) |
Filing History |
| 2023-06-21 4:33 pm Purchase |
2023-06-16 | 13D | Pharvaris N.V. PHVS |
venBio Global Strategic Fund III L.P. | 4,264,672 10.400% |
1,963,221 (+85.30%) |
Filing History |
| 2023-02-14 1:18 pm Purchase |
2022-12-31 | 13G | Pharvaris N.V. PHVS |
VIKING GLOBAL INVESTORS LP | 3,231,923 9.700% |
776,387 (+31.62%) |
Filing History |
| 2023-02-13 4:56 pm Sale |
2022-12-31 | 13G | Pharvaris N.V. PHVS |
Foresite Capital Fund IV, L.P. | 3,281,068 9.700% |
-15,000 (-0.46%) |
Filing History |
| 2023-02-09 12:01 pm Purchase |
2023-02-09 | 13G | Pharvaris N.V. PHVS |
FMR CORP | 3,315,238 9.999% |
20,129 (+0.61%) |
Filing History |
| 2022-09-26 4:24 pm Sale |
2021-02-09 | 13D | Pharvaris N.V. PHVS |
venBio Global Strategic Fund III L.P. | 2,301,451 6.900% |
-1,859 (-0.08%) |
Filing History |
| 2022-02-14 5:01 pm Purchase |
2021-12-31 | 13G | Pharvaris N.V. PHVS |
VIKING GLOBAL INVESTORS LP | 2,455,536 7.400% |
35,381 (+1.46%) |
Filing History |
| 2022-02-11 3:12 pm Sale |
2021-12-31 | 13G | Pharvaris N.V. PHVS |
Foresite Capital Fund IV, L.P. | 3,296,068 9.900% |
-630,000 (-16.05%) |
Filing History |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | Pharvaris N.V. PHVS |
FMR CORP | 3,295,109 9.946% |
3,295,109 (New Position) |
Filing History |
| 2022-02-03 4:18 pm Purchase |
2021-12-31 | 13G | Pharvaris N.V. PHVS |
LSP V Cooperatieve U.A. | 3,607,566 10.900% |
3,607,566 (New Position) |
Filing History |